US/UK/Canada

Share

Quotes

Tridentify's solution can play a crucial role in meeting the new stringent SoHO directive and ensuring life-saving quality for patients.
Johan Stormlund, CEO, Tridentify.
We are excited to announce the launch of our new real-time monitoring system with stability budget monitoring. This new system will revolutionise the way businesses monitor their operations and manage their shipments, providing a comprehensive view of product stability in real-time.
Johan Stormlund, CEO of Tridentify.
Pick a time period -
Tags ( Active)

Intrance Medical Systems Inc signs LOI purchase commitment for clinical trials with Parkinson’s diseases patients

Tridentify are delighted to announce that Intrance Medical Systems Inc. now have signed a LOI purchase commitment of $ 300 000. Our Tridentify safeguarding solution will be used for the “logistic journey” of the drug component for clinical trials in at least Europe and the US for patients with Parkinson diseases in advanced stage. The clinical development program for US registration has recently been initiated, with a larger more extensive study planned for late 2024.- Intrance Medical Systems is focused on the development and commercialization of its lead clinical product for the treatment

1,5 million blood bags discarded each year due to transport and storage issues

More than 1,5 million blood bags are discarded every year after transportation and storage problems, according to the World Health Organization, WHO.[1] Meanwhile, there is a blood shortage during operations, even though 118,5 million blood bags are altruistically donated by people all over the world,[2] for the sake of others.One unit of blood can save up to three lives and can only be aggregated through human donors. 1,5 million wasted blood bags equals 4,5 million potential saved lives each year. This also means that every year, blood worth up to € 350 million goes to waste - equivalent

Tridentify launches a unique real-time monitoring and decision-support system for the cold-chain

Tridentify, an international provider of cold-chain monitoring solutions, has announced the launch of its latest innovation - a real-time cold chain monitoring system that includes a ground-breaking feature for continuously monitoring the stability and remaining shelf-life of shipped products in the cold-chain. The new system will transform the way companies monitor their operations and manage their stability budgets by providing a comprehensive view of the stability and the remaining shelf-life of the pharmaceutical products in real time.The new system provides an accurate and real-time

Tridentify AB signs Letter of Intent with Intrance Medical Systems Inc regarding purchase and delivery of its SaaS based cold chain safeguarding service

Tridentify AB has today signed a Letter of Intent (LOI) with Intrance Medical Systems regarding purchase and delivery of the Tridentify Tracer Solution. The Seller (Tridentify AB) has developed an advanced SaaS and IoT system for the real time monitoring and continuous stability control of pharmaceuticals in the cold chain.   The Buyer (Intrance Medical Systems Inc) has developed a drug/device treatment system for patients suffering from Parkinson´s diseases in an advanced stage. The drug component is expected to be delivered internationally and need to be transported under

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe

Media